or
Bookmark and Share
   
Document Number
US Patent 6790960
Issued Date
September 14, 2004
Link
Inventors
Map
Abstract
The present invention relates to novel compounds, and therapeutically acceptable salts thereof of the formula (I), which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases. ##STR1##
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
14
Comments:
no comments yet
Owner
AstraZeneca AB (Sodertalje,SE)
Published
September 14, 2004
Application Number
10/429,639
Filed
May 5, 2003
US Classification
546/121   546/112 546/113
Int'l Classification
A61K   45/06   (20060101)   C07D   471/04   (20060101)   A61K   45/00   (20060101)   A61K   31/4353   (20060101)   A61K   31/437   (20060101)   C07D   471/00   (20060101)  
Attorney/Law Firm
Parent Case
This application is a continuation of U.S. patent application Ser. No. 09/402,919, filed Oct. 13, 1999, now U.S. Pat. No. 6,579,884 which is a .sctn.371 of international patent application PCT/SE99/01402, filed Aug. 18, 1999.
Priority Data
Aug 21, 1998 [SE] 9802794
USPTO Field of Search
546/121   546/113   546/112   514/300  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us